Adjunctive value of cell proliferation but not of apoptosis to interpret pathologic effects on prostatic cancer after neoadjuvant endocrine therapy.

Maeda, O; Kinouchi, T; Meguro, N; Saiki, S; Kuroda, M; Usami, M; Wada, A; Kotake, T

Maeda, O; Kinouchi, T; Meguro, N; Saiki, S; Kuroda, M; Usami, M; Wada, A; Kotake, T.

Affiliation

Maeda O; Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan.

Jpn J Clin Oncol ; 28(4): 262-6, 1998 Apr.

Article in En | MEDLINE | ID: mdl-9657012

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Diethylstilbestrol/therapeutic use; Gonadotropin-Releasing Hormone/agonists; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/pathology; Aged; Apoptosis; Cell Division; Chemotherapy, Adjuvant; Humans; Male; Middle Aged; Prognosis; Prostatectomy; Prostatic Neoplasms/surgery

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Gonadotropin-Releasing Hormone / Antineoplastic Agents, Hormonal / Diethylstilbestrol Type of study: Prognostic_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 1998 Document type: Article

Search on Google

XML

PubMed Links